Shockwave Medical, Inc.
SWAV
$330.49
$0.490.15%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -68.56% | -0.05% | 12.91% | 169.44% | 988.79% |
| Total Depreciation and Amortization | 99.93% | 139.19% | 131.80% | 79.22% | 72.04% |
| Total Amortization of Deferred Charges | 1,475.00% | 203.07% | -77.71% | -78.43% | -61.04% |
| Total Other Non-Cash Items | 121.40% | 98.75% | 32.66% | 48.04% | -995.28% |
| Change in Net Operating Assets | 200.33% | 3.68% | 10.51% | 7.12% | -97.04% |
| Cash from Operations | 36.74% | 46.87% | 37.64% | 1,653.33% | 151.72% |
| Capital Expenditure | 26.71% | 8.65% | -142.87% | -118.75% | -292.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -867.72% | -16,013.93% | 105.89% | 155.41% | -19.31% |
| Cash from Investing | -586.76% | -5,697.55% | -1,540.30% | 122.55% | -52.70% |
| Total Debt Issued | -101.46% | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -809.09% | -- | -- | -- |
| Issuance of Common Stock | -78.43% | 14.81% | -19.40% | 35.08% | 78.00% |
| Repurchase of Common Stock | 88.24% | -- | -- | 50.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.71% | 159,951.44% | -19,268.20% | 3,209.88% | 1,819.20% |
| Foreign Exchange rate Adjustments | -31.34% | 37.10% | 78.90% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -698.15% | 1,158.53% | -516.49% | 641.64% | 1,701.24% |
